Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical

BiCNU supply shortage

  • News

Executive Summary

Bristol-Myers Squibb is experiencing a supply outage of BiCNU (carmustine injection) chemotherapy, the drug maker reports Oct. 6. Bristol has not confirmed an availability date for the product, but says it is working to resolve the outage. The company is encouraging physicians and health care providers to use alternative treatments when possible. Supply issues due to production delays also occurred in May. BiCNU is indicated for palliative therapy in the treatment of brain tumors, multiple myeloma, Hodgkin's disease and non-Hodgkin's lymphoma...

Table

View full table

Topics

Tags:
BioPharmaceutical
Latest Headlines

Asian Industry Groups Push For Universal Care, E-Labeling, Flexible Supply Chain

US FDA Developing Model Master File System To Grow Modeling, Simulation Field

US FDA May User Fee Preview: Vaccines, Gene Therapy, And Double Oncologics

Pharma’s IRA Complaints Find Sympathetic Ear In US Appeals Court But Near-Term Relief Unlikely

See All
UsernamePublicRestriction

Register

PS046399

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By